Ambulatory Measurement of Physical Activity in Pancreatic Cancer Patients

• Register: ClinicalTrials.gov
• Last refreshed on: 7 February 2022
• Main ID: NCT03490604
• Date of registration: 30/03/2018
• Prospective Registration: Yes
• Primary sponsor: Centre Hospitalier Universitaire Dijon
• Public title: Ambulatory Measurement of Physical Activity in Pancreatic Cancer Patients ARABICA
• Scientific title: Ambulatory Measurement of Physical Activity in Pancreatic Cancer Patients
• Date of first enrolment: July 2, 2018
• Target sample size: 30
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT03490604
• Study type: Observational

Countries of recruitment

France

Key inclusion & exclusion criteria

Inclusion Criteria:

- Patient with unresectable pancreatic adenocarcinoma for whom an indication for
chemotherapy has been decided upon after a multidisciplinary consultation meeting;

- Adult patient;

- Patients able to understand spoken and written French,

- Patient has given consent.

Exclusion Criteria:

- WHO ECOG stage III or IV ;

- Patient suffering from a major physical disability (hemiplegia, paraplegia, myopathy,
amputation of a limb);

- Any alteration of comprehension capacities making self-evaluation impossible;

- Protected adult;

- Patient not affiliated to a national health insurance scheme;

- Pregnant or nursing women.



Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Unresectable Pancreatic Adenocarcinoma

Intervention(s)

Device: wrist-worn accelerometer

Other: Auto-questionnaires

Primary Outcome(s)

average time wearing the accelerometer, in hours [Time Frame: every 2 weeks for 6 months]

Secondary ID(s)

DROUILLARD AOI 2017

Source(s) of Monetary Support

Please refer to primary and secondary sponsors